Eiger BiopharmaceuticalsEIGRQ
13F holders, Q2 2024 (June 30)2holders −22
0new positions
23sold out
$12.65avg. 13F price*
At the end of Q2 2024, 2 institutions reported holding Eiger Biopharmaceuticals Inc. (EIGRQ) in their 13F filings, down 22 from Q1 2024. 0 opened new positions and 23 sold out. The largest holders were Propel Bio Management, LLC ($1.9M) and Osaic Holdings, Inc. ($543).
- Company
- Eiger Biopharmaceuticals Inc.
- CUSIP
- 28249U204
- Latest filing quarter
- Q2 2025
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 23 | $2.5M |
All 13F filers, Q1 2024 → Q2 2024: 520,411 shares sold, net −520,411 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 2 holders
| Propel Bio Management, LLC | 1.20% | No change | 146,381 | $1.9M |
| Osaic Holdings, Inc. | 0.00% | Reduce -87.0% | 43 | $543 |
"% of holder's portfolio" is EIGRQ's weight in each manager's 13F, not the share of Eiger Biopharmaceuticals Inc. the manager owns.